Cargando…
Inhibition of T Cell Protein Tyrosine Phosphatase Enhances Interleukin-18-Dependent Hematopoietic Stem Cell Expansion
The clinical application of hematopoietic progenitor cell-based therapies for the treatment of hematological diseases is hindered by current protocols, which are cumbersome and have limited efficacy to augment the progenitor cell pool. We report that inhibition of T-cell protein tyrosine phosphatase...
Autores principales: | Bourdeau, Annie, Trop, Sébastien, Doody, Karen M, Dumont, Daniel J, Tremblayef, Michel L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Subscription Services, Inc., A Wiley Company
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3593175/ https://www.ncbi.nlm.nih.gov/pubmed/23135963 http://dx.doi.org/10.1002/stem.1276 |
Ejemplares similares
-
Activation of Notch Signaling During Ex Vivo Expansion Maintains Donor Muscle Cell Engraftment, ,
por: Parker, Maura H., et al.
Publicado: (2012) -
In Utero Transplantation of Expanded Autologous Amniotic Fluid Stem Cells Results in Long‐Term Hematopoietic Engraftment
por: Loukogeorgakis, Stavros P., et al.
Publicado: (2019) -
Fisetin Attenuates Cellular Senescence Accumulation During Culture Expansion of Human Adipose-Derived Stem Cells
por: Mullen, Michael, et al.
Publicado: (2023) -
Cellular Reprogramming Allows Generation of Autologous Hematopoietic Progenitors From AML Patients That Are Devoid of Patient-Specific Genomic Aberrations
por: Salci, Kyle R, et al.
Publicado: (2015) -
Design and Validation of an Automated Process for the Expansion of Peripheral Blood‐Derived CD34(+) Cells for Clinical Use After Myocardial Infarction
por: Saucourt, Claire, et al.
Publicado: (2019)